ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1537

Primary & Subsequent Orthopedic Surgeries More Common In Juvenile Vs. Adult-Onset Ankylosing Spondylitis

Deepak R. Jadon1, Ramani Arumugam1, Gavin Shaddick2, Alison L Nightingale3, Athimalaipet V Ramanan4 and Raj Sengupta1, 1Rheumatology, Royal National Hospital for Rheumatic Diseases, Bath, United Kingdom, 2Department of Mathematics, University of Bath, Bath, United Kingdom, 3Pharmacy and Pharmacology, University of Bath, Bath, United Kingdom, 4Paediatric Rheumatology, University of Bristol Hospital Trust, Bristol, United Kingdom

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Ankylosing spondylitis (AS), Juvenile Arthritis, prognostic factors, spondylarthropathy and surgery

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Spondylarthropathies and Psoriatic Arthritis: Clinical Aspects and Treatment: II

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Patients experiencing ankylosing spondylitis (AS) symptoms ²16 years-of-age are classified as juvenile-onset AS (JoAS), whilst those ³17 years adult-onset AS (AoAS). We compared JoAS and AoAS cases with respect to proceeding to orthopedic surgery, date and type of surgery, and revisions.

Methods:

A cross-sectional observational cohort study was conducted of all AS patients attending a secondary care rheumatology hospital since 1970.

The following were recorded: sex, age at symptom onset, age at diagnosis, HLA-B27 genotype status, smoking history, peripheral arthritis, psoriasis, uveitis, enthesitis, inflammatory bowel disease, family history of spondyloarthropathy (SpA), and AS-related orthopedic surgery.

Univariate analyses used t-tests and Fisher’s exact tests for continuous and categorical variables, respectively. Multivariate analyses were performed using logistic regression with variable selection based on stepwise selection.

Results:

143 JoAS were compared with 411 AoAS patients. At assessment, JoAS were slightly younger than AoAS cases (mean difference 2.9 years), and had slightly longer disease duration since diagnosis (26.0 vs.19.3 years). No statistically significant differences were found between the two groups in terms of sex distribution, HLA-B27 positivity, psoriasis, enthesitis or uveitis.

JoAS cases (n=29/143) were more likely to have had AS-related surgery than AoAS cases (n=29/411) even after adjusting for longer time since diagnosis (p=0.017).

Direct comparisons were then made of JoAS and AoAS cases proceeding to surgery (Table 1). No significant difference was found in the disease durations of JoAS and AoAS surgical cases to first surgery (diagnosis to first surgery, p=0.458; or symptom onset to first surgery, p=0.724).

The likelihood of second surgery (of any type) in AoAS cases was significantly less than for JoAS cases (adjusted analysis: OR 0.277; 95% CI 0.078-0.980; p=0.047).

Considering the likelihood of having a second surgery in the AS surgical cohort, smoking (OR 6.559 for ever having smoked vs. never smoked; p=0.097) and HLA-B27 positivity (OR 1.002; p=0.054) were significant predictors.

Considering the likelihood of having a hip procedure (arthroplasty or resurfacing), family history of SpA (OR 0.999; p=0.05) and age of symptom onset (OR 0.997; p=0.09) were significant predictors.

Most AoAS cases had their hip arthroplasty by 20 years disease duration (n=22), thereafter the procedure was infrequent (n=2 of 36 potential native hips).

Conclusion:

This is the largest reported study of detailed AS-related orthopedic surgery data comparing JoAS with AoAS cases. JoAS cases were more likely to proceed to surgery, and have had a second surgery, even after adjusting for a longer disease duration. Smoking and HLA-B27 positivity were predictors of a second surgery; age of symptom onset and family history of SpA were predictors of hip surgery.

Table 1.

PROCEDURE

SURGERY

ROW TOTALS

1st

2nd

3rd

4th

5th

6th

7th

8th

JoAS

AoAS

JoAS

AoAS

JoAS

AoAS

JoAS

AoAS

JoAS

AoAS

JoAS

AoAS

JoAS

AoAS

JoAS

AoAS

Hip arthroplasty

19

20

13

13

3

0

0

0

0

0

0

0

0

0

0

0

68

Hip resurfacing

7

3

3

2

1

0

0

0

0

0

0

0

0

0

0

0

16

Knee replacement

0

0

0

1

0

0

0

0

0

0

0

0

0

0

0

0

1

Knee arthroscopy

1

1

4

0

0

0

1

0

0

0

0

0

0

0

0

0

7

Lumbar laminectomy

0

1

0

0

0

0

0

0

0

0

0

0

0

0

0

0

1

Lumbar osteotomy

1

2

0

0

0

0

0

1

0

0

0

0

0

0

0

0

4

Spinal fusion

0

1

0

0

0

1

1

0

0

0

0

0

0

0

0

0

3

Wrist fusion

0

0

1

0

0

0

0

0

0

0

0

0

0

0

0

0

1

Tendon surgery

1

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

1

Hip revision

0

0

2

1

8

5

5

2

4

2

4

0

1

0

1

0

35

ACL repair

0

1

0

0

0

0

0

0

0

0

0

0

0

0

0

0

1

Shoulder hemiarthroplasty

0

0

0

0

0

0

0

0

1

0

0

0

0

0

0

0

1

COLUMN TOTALS

29

29

23

17

12

6

7

3

5

2

4

0

1

0

1

0

COLUMN TOTALS

58

40

18

10

7

4

1

1

139


Disclosure:

D. R. Jadon,
None;

R. Arumugam,
None;

G. Shaddick,
None;

A. L. Nightingale,
None;

A. V. Ramanan,
None;

R. Sengupta,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/primary-subsequent-orthopedic-surgeries-more-common-in-juvenile-vs-adult-onset-ankylosing-spondylitis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology